- Article
Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
- Alexander Nikoloudis,
- Irene Strassl,
- Michaela Binder,
- Olga Stiefel,
- Dagmar Wipplinger,
- Robert Milanov,
- Christoph Aichinger,
- Emine Kaynak,
- Sigrid Machherndl-Spandl and
- Johannes Clausen
- + 6 authors
Background: Serotherapy with anti-T lymphocyte globulin (ATLG, Grafalon, formerly ATG-Fresenius) is established for the prevention of severe graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT). The evidence from pros...

